Financial Performance - The company reported a total revenue of 970,863,773 RMB for the year 2023, with no cash dividends or stock bonuses distributed to shareholders [4]. - The company's operating revenue for 2023 was ¥335,845,163.44, a decrease of 43.67% compared to ¥596,198,779.17 in 2022 [19]. - The net profit attributable to shareholders for 2023 was -¥397,132,196.33, a significant decline from a profit of ¥17,950,625.87 in 2022, representing a decrease of 2,312.36% [19]. - The basic earnings per share for 2023 was -¥0.41, compared to ¥0.02 in 2022, reflecting a decline of 2,150.00% [19]. - The company reported a total of ¥60,657,331.42 in non-recurring losses for 2023, compared to -¥43,737,632.16 in 2022 [24]. - The company achieved operating revenue of 335.84 million yuan, a decrease of 43.67% year-on-year, with film and television sales revenue down 48.89% [32]. - The company reported a net profit attributable to shareholders of -397.13 million yuan, a decrease of 2,312.36 million yuan compared to the previous year [32]. - The company's cash flow from operating activities was a net inflow of 178.85 million yuan, an increase of 1,907.17 million yuan year-on-year [32]. - The company’s monetary funds at the end of the year were 579.44 million yuan, an increase of 48.03% compared to the end of the previous year [32]. Risk Management and Governance - The company emphasizes the importance of risk awareness among investors regarding forward-looking statements and potential risks outlined in the report [4]. - The management discussion section highlights the company's future development outlook and potential risks it may face, although specific numerical forecasts are not provided [4]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profits over the last three accounting years [20]. - The company maintains a commitment to transparency and accuracy in its financial reporting, as stated by its management team [4]. - The company has established a robust corporate governance structure, adhering to relevant laws and regulations, ensuring transparency and protecting investor rights [98]. - The company emphasizes strict information disclosure, maintaining transparency and fairness in communication with investors [101]. - The company actively engages with investors through various channels, enhancing communication and addressing investor concerns [102]. Shareholder Engagement and Board Activities - The report indicates that all board members attended the meeting to review the annual report, ensuring collective accountability [4]. - In 2023, the company held 4 shareholder meetings and approved 23 resolutions, including 7 sub-resolutions [99]. - The board of directors convened 8 meetings, passing 43 resolutions, with 2 out of 5 members being independent directors [99]. - The supervisory board held 5 meetings, approving 10 resolutions, ensuring oversight of financial and managerial compliance [100]. - The company held four shareholder meetings during the reporting period, with participation rates of 37.89%, 39.81%, 36.49%, and 37.61% respectively [104]. Strategic Direction and Business Development - The company has not disclosed any new product launches or technological advancements in the current report, focusing instead on financial performance and risk management [4]. - The company is actively exploring new business directions, including short dramas, interactive dramas, AIGC, and film technology, with a dedicated team established for these initiatives [38]. - The company is focusing on the development of AIGC technology, which is expected to enhance script creation and special effects production efficiency [31]. - The company plans to launch several new film projects in 2024, including titles such as "Deep Dive" and "Ten Years of Warmth," aiming to enhance production quality and optimize project investment returns [89]. Financial Management and Internal Controls - The company has improved its governance system to ensure good cash flow and financial reserves, enhancing its financial management framework [40]. - The internal control system has been updated and improved according to the basic norms of internal control, effectively preventing operational risks [133]. - The internal control audit report indicates that the company maintained effective financial reporting internal controls as of December 31, 2023 [137]. - The company reported no discrepancies in the supervisory activities conducted by the supervisory board during the reporting period [124]. Legal and Compliance Issues - The company has received a total of 1,043 lawsuits related to false securities statements, with a total claimed amount of 183.57 million RMB as of December 31, 2023 [158]. - The estimated liability for these lawsuits is 16.09 million RMB, with 1,040 cases settled and 3 cases withdrawn [158]. - The company has ongoing litigation involving an estimated amount of 355.76 million RMB, with an estimated liability balance of 16.30 million RMB [158]. - The company has faced regulatory scrutiny, with chairman Zhao Zhicheng receiving a public reprimand from the Shenzhen Stock Exchange for violations of the Securities Law [113]. Employee Management and Development - The total number of employees at the end of the reporting period is 125, with 22 in the parent company and 103 in major subsidiaries [125]. - The professional composition includes 69 production personnel, 5 sales personnel, 20 technical personnel, 14 financial personnel, and 17 administrative personnel [125]. - Employee training and development are prioritized, with management participating in advanced studies to enhance skills and knowledge [127]. - The company emphasizes a performance-based compensation policy to attract and retain talent, ensuring competitive salaries [126]. Profit Distribution and Shareholder Returns - The board of directors has approved a profit distribution plan based on the aforementioned revenue figure, indicating a cautious approach to shareholder returns [4]. - The company's distributable profits for the consolidated and parent company reports for 2023 are -987,762,631.27 CNY and -664,745,884.33 CNY respectively, indicating negative distributable profits and non-compliance with cash dividend conditions [130]. - There were no cash dividends proposed during the reporting period, with a total cash dividend amount of 0.00 CNY [129]. - The company plans not to distribute profits for the 2023 fiscal year to ensure sufficient funding for long-term development and to provide stable returns to investors [131].

Financial Performance - The company's operating revenue for Q1 2024 was ¥71,846,327.25, representing a 32.41% increase compared to ¥54,259,230.62 in the same period last year[5] - Net profit attributable to shareholders was ¥14,881,833.95, an increase of 88.32% from ¥7,902,384.82 year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥14,014,206.91, up 95.48% from ¥7,169,215.98 in the previous year[5] - The net profit for Q1 2024 was CNY 14,838,439.56, a significant increase of 92.5% compared to CNY 7,713,430.00 in Q1 2023[19] - Operating profit for Q1 2024 reached CNY 18,039,786.52, up from CNY 11,021,697.44 in the same period last year, reflecting a growth of 63.7%[19] - The company reported a total comprehensive income of CNY 14,838,439.56 for Q1 2024, compared to CNY 7,713,430.00 in Q1 2023[19] - Basic and diluted earnings per share for Q1 2024 were both CNY 0.0153, up from CNY 0.0081 in the previous year[19] Cash Flow and Assets - The net cash flow from operating activities was -¥30,767,267.06, a decrease of 129.66% compared to ¥103,717,706.14 in the same period last year[5] - The company's cash and cash equivalents decreased to RMB 551,688,557.06 from RMB 579,439,481.02, a decline of 4.9%[14] - Cash and cash equivalents at the end of Q1 2024 stood at CNY 520,700,412.16, a decrease from CNY 542,838,320.82 at the beginning of the quarter[21] Liabilities and Shareholder Information - The company's contract liabilities increased by 35.58% to ¥200,424,320.38, primarily due to new pre-sale payments received for film and television projects[8] - Short-term borrowings increased to RMB 100,000,000.00 from RMB 90,000,000.00, reflecting a rise of 11.1%[15] - The total liabilities amounted to RMB 980,980,473.00, showing a slight increase from RMB 980,980,473.00 in the previous period[16] - The number of ordinary shareholders at the end of the reporting period was 42,348, indicating a stable shareholder base[10] Operating Costs and Expenses - The company reported a significant increase in operating costs, which rose by 37.79% to ¥27,715,576.52, attributed to increased IP copyright sales[9] - Total operating costs for Q1 2024 were RMB 50,854,353.16, up from RMB 48,957,927.55 in the previous year, reflecting a year-over-year increase of 3.7%[18] - Research and development expenses amounted to ¥633,679.44, indicating a 100% increase due to new R&D initiatives[9] - Research and development expenses were CNY 633,679.44, indicating ongoing investment in innovation[19] Asset Growth - Total assets at the end of the reporting period were ¥1,814,309,955.39, a 2.54% increase from ¥1,769,284,149.92 at the end of the previous year[5] - The total assets of the company reached RMB 1,814,309,955.39, compared to RMB 1,769,284,149.92 at the beginning of the period, an increase of 2.5%[16] - Accounts receivable increased to RMB 196,285,296.24 from RMB 191,885,697.10, showing a growth of 2.3%[14] - Inventory rose to RMB 627,129,287.63, up from RMB 565,665,663.14, representing an increase of 10.9%[15]

关于对深圳证券交易所上市公司管理二部 问询欢瑞世纪联合股份有限公司 2020 年报的回复 欢瑞世纪联合股份有限公司: 根据委托,中天运会计师事务所(特殊普通合伙)对贵公司 2020年度的财 务报告进行了审计。深圳证券交易所公司管理部于 2021年 6月 11 日发布的《关 于对欢瑞世纪联合股份有限公司 2020 年年报的问询函》(公司部年报问询函 (2021)第 389 号)我们已收悉,现将所涉事项需要会计师回复的部分回复如下: 一、年报显示,年审会计师因电视剧《天下长安》在 2018年存在未按卫视 计划档期播出且至 2020年审计报告日仍未播出的情况,对你公司 2019年及 2020 年财务报表出具了保留意见。合同资产账面余额为 4.37 亿元(与 2019年期末会 额 4.41 亿元的差异为汇兑损失),你按照账龄组合计量预期信用损失累计计提 减值准备 4.37 亿元(其中:2020年计提 2.55 亿元),账面价值为零。电视剧《封 神之天启》因政策原因无法播出,你公司根据退片及播出等概率计提坏账 2.14 亿元。请你公司补充披露上述两部影片的具体情况,包括影视作品名称、合作 方、公司投入金额及投资占比、投 ...

证券代码：000892 证券简称：欢瑞世纪 公告编号：2024-07 欢瑞世纪联合股份有限公司 关于公司持股 5%以上股东部分股份将被司法拍卖 暨可能被动减持的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、公司持股 5%以上股东浙江欢瑞世纪文化艺术发展有限公司（以下简称 "浙江欢瑞"），与钟君艳、陈援、钟金章、陈平、钟开阳共为一致行动人， 合计持有本公司股份 123,754,012 股，占公司总股本的 12.62%。本次司法拍卖 的标的物为浙江欢瑞所持有的本公司共计 49,194,111 股限售股股票，占公司总 股本的 5.01%。 2、根据上述一致行动人（钟开阳除外）与本公司于 2015 年签订的《利润补 偿协议》，本次拟被司法拍卖的股份具有业绩补偿的义务。故如前述股份若被 拍卖，受让方应同时承担该股份应履行的承诺事项，即前述的业绩补偿承诺及 其他相关承诺，若欢瑞影视未能完成业绩承诺，该部分股份存在被用于履行业 绩补偿义务的不确定性。 3、浙江欢瑞所持本公司的股票被法院第一次拍卖已流拍，本次为第二次拍 卖。本次司法拍卖事项后续将涉 ...

证券代码：000892 证券简称：欢瑞世纪 公告编号：2024- 本公司（包括使用募集资金的全资子公司）与独立财务顾问新时代证券股份有限公司 （现更名为诚通证券股份有限公司，下同）分别于2017年1月19日、2017年8月11日、2018 年3月20日、2020年1月20日、2020年2月12日、2020年2月25日及2022年6月20日分别与民 生银行北京广安门支行、中信银行金华东阳支行、中信银行金华东阳支行、浙商银行金华 分行等签署了《募集资金三方监管协议》，明确了各方的权利和义务。三方监管协议与深 圳证券交易所三方监管协议范本不存在重大差异，本公司在使用募集资金时已经严格遵照 履行（以上详情请见本公司分别于2017年1月19日、2017年8月15日、2018年3月21日、 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、募集资金基本情况 2016 年 11 月 8 日，欢瑞世纪联合股份有限公司（以下简称"公司"、"本公司"）收到 中国证券监督管理委员会《关于核准星美联合股份有限公司向钟君艳等发行股份购买资产 并募集配套资金的批复》（证监许可[2016 ...

证券代码：000892 证券简称：欢瑞世纪 公告编号：2024-05 欢瑞世纪联合股份有限公司 关于公司持股 5%以上股东部分股份将被司法拍卖 暨可能被动减持的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、公司持股 5%以上股东浙江欢瑞世纪文化艺术发展有限公司（以下简称 "浙江欢瑞"），与钟君艳、陈援、钟金章、陈平、钟开阳共为一致行动人， 合计持有本公司股份 123,754,012 股，占公司总股本的 12.62%。本次司法拍卖 的标的物为浙江欢瑞所持有的本公司有限售条件的流通股共计 49,194,111 股， 占公司总股本的 5.01%。 2、根据上述一致行动人（钟开阳除外）与本公司于 2015 年签订的《利润 补偿协议》，本次拟被司法拍卖的股份具有业绩补偿的义务。故如前述股份若 被拍卖，受让方应同时承担该股份应履行的承诺事项，即前述的业绩补偿承诺 及其他相关承诺，若欢瑞影视未能完成业绩承诺，该部分股份存在被用于履行 业绩补偿义务的不确定性。 一、股东股份拟将被司法拍卖的基本情况 欢瑞世纪联合股份有限公司（以下简称"欢瑞世纪"或" ...

证券代码：000892 证券简称：欢瑞世纪 公告编号：2024-04 欢瑞世纪联合股份有限公司 关于公司股东部分股份将被司法拍卖的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、公司持股 5%以上股东钟君艳，与陈援、浙江欢瑞世纪文化艺术发展有限 公司（以下简称"浙江欢瑞"）、钟金章、陈平、钟开阳共为一致行动人，合计 持有本公司股份 123,754,012 股，占公司总股本的 12.62%。本次司法拍卖标的 物为钟金章持有的本公司共计 2,357,409股限售股股票，占公司总股本的0.24%。 2、本次司法拍卖事项后续将涉及竞拍、缴款、股权变更过户等环节，拍卖 结果尚存在一定的不确定性，公司将密切关注该事项的后续进展情况并及时履 行信息披露义务。 一、股东股份拟将被司法拍卖的基本情况 欢瑞世纪联合股份有限公司（以下简称"欢瑞世纪"或"本公司"）曾于 2023 年 11 月 14 日、12 月 5 日分别披露了《关于公司股东收到执行裁定书的公告》 《关于公司股东部分股份将被司法拍卖的进展公告》（公告编号：2023-66、2023- 71） ...

欢瑞世纪联合股份有限公司 独立董事专门会议制度 （经 2024 年 1 月 9 日公司第九届董事会第九次会议审议通过） 第一条 为保证欢瑞世纪联合股份有限公司（以下简称"公司"或"本公司"）独立董事专 门会议的议事方式和决策程序，促使并保障独立董事有效地履行其职责。根据《中华人民 共和国公司法》《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》（《深圳证 券交易所上市公司自律监管指引第 1 号-主板上市公司规范运作》等有关法律、行政法规、 部门规章和规范性文件和《欢瑞世纪联合股份有限公司章程》（以下简称"《公司章程》"） 的相关规定和要求，制订本制度。 第二条 独立董事专门会议是指全部由公司独立董事参加的会议。 第三条 公司独立董事定期或不定期召开独立董事专门会议，并于会议召开前三天以包 括但不限于邮件、短信、微信等方式通知全体独立董事并提供相关资料和信息。经全体独 立董事一致同意，通知时限可不受本条款限制。 第四条 独立董事专门会议可通过现场、电子通讯方式（含视频、电话等）或现场与电 子通讯相结合的方式召开；半数以上独立董事提议可召开临时会议。 第五条 独立董事专门会议由三分之二以上独立董事出席或委 ...

证券代码：000892 证券简称：欢瑞世纪 公告编号：2024-02 欢瑞世纪联合股份有限公司 关于2024年度日常关联交易预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述 欢瑞世纪联合股份有限公司（以下简称"公司""本公司"）就 2024 年度公司 及下属公司与公司参股企业东阳烨华影视有限公司（以下简称"东阳烨华"）拟发生 日常关联交易进行了预计，预计 2024 年度与关联方发生的日常关联交易合计 6450 万 元。2023 年度同类交易实际发生金额为 0 元。 2024 年 1 月 9 日，本公司以现场会议方式召开了第九届董事会第九次会议，以 4 票同意、1 票回避表决、0 票反对、0 票弃权，审议通过了《关于 2024 年度日常关联 交易预计的议案》。关联董事赵会强对该项议案予以回避表决。 2024 年公司预计与关联方发生的日常关联交易超过三千万元，但未超过公司最近 一期经审计净资产绝对值的 5%，根据《深圳证券交易所股票上市规则》以及《公司章 程》的规定，本议案在公司董事会审批权限范围内，无需 ...

欢瑞世纪联合股份有限公司 第九届董事会第九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 证券代码：000892 证券简称：欢瑞世纪 公告编号：2024-01 独立董事专门会议对该项议案的审核意见及其它所涉内容请详见与本公告同日 披露在巨潮资讯网上的《关于 2024 年度日常关联交易预计的公告》。 （二）审议通过了《关于制订<独立董事专门会议制度>的议案》，表决结果为： 5 票同意，0 票反对，0 票弃权，该议案获得表决通过。 详情请见与本公告同日刊登在巨潮资讯网上的《独立董事专门会议制度》。 （一）本次会议是欢瑞世纪联合股份有限公司（以下简称"本公司"或"公司"） 第九届董事会第九次会议。会议通知于 2024 年 1 月 8 日以电子邮件、微信等方式送 达各位董事，会议召集人对会议召开情况进行了说明。 （二）本次会议于 2024 年 1 月 9 日 13:30 在北京市朝阳区望京东园四区 1 号楼 君康人寿大厦 30 层以现场会议方式召开。 （三）本次会议应到董事 5 名，实到董事 5 名。 （四）会议由公司董事长赵枳 ...